BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4704577)

  • 1. [Use of non-aqueous solvents in preparing solutions of some N-acetylsarcolysine peptides].
    Safonov VP; Lopatin PV; Litvinova TP
    Farmatsiia; 1973; 22(1):16-20. PubMed ID: 4704577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electron paramagnetic resonance in solutions of oxidized sarcolysin and other antineoplastic agents].
    Kozyrev BM; Rivkind AI
    Dokl Akad Nauk SSSR; 1967 Aug; 175(6):1396-9. PubMed ID: 4317674
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity and antineoplastic activity of asalei (ethyl ester of acetyl-sarcolysine-L-leucine).
    Larionov LF; Bukharova IK; Shamaeva EM
    Fed Proc Transl Suppl; 1966; 25(1):77-8. PubMed ID: 5215810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Process of antitumor preparation solubilization].
    Murav'ev IA; Semenchenko VF
    Farmatsiia; 1978; 27(2):13-5. PubMed ID: 640027
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source.
    Druml W; Roth E; Lenz K; Lochs H; Kopsa H
    Kidney Int Suppl; 1989 Nov; 27():S282-6. PubMed ID: 2517676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of sarcolysine and two stereoisomers of asaphane upon oxidative phosphorylation in mitochondria from tumour and liver of rat].
    Romanova IN; Sof'ina ZP
    Vopr Med Khim; 1969; 15(1):47-52. PubMed ID: 5822029
    [No Abstract]   [Full Text] [Related]  

  • 7. [The anti-tumor activity of several N-acetyl-sarcolysin derivatives in the form of non-aqueous solutions].
    Lopatin PV; Safonov VP; Litvinova TP
    Farmakol Toksikol; 1973; 26(4):479-80. PubMed ID: 4789902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
    Zhou JX; Liang HZ; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
    [No Abstract]   [Full Text] [Related]  

  • 9. Conformational analysis of the tyrosine dipeptide analogue in the gas phase and in aqueous solution by a density functional/continuum solvent model.
    Langella E; Rega N; Improta R; Crescenzi O; Barone V
    J Comput Chem; 2002 Apr; 23(6):650-61. PubMed ID: 11939597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of -radiation on concentrated solutions of -chymotrypsin.
    Lynn KR
    Radiat Res; 1972 Jan; 49(1):51-62. PubMed ID: 5009149
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of pepsin specificity in transpeptidation reactions].
    Mal'tsev NI; Ginodman LM; Orekhovich VN; Valueva TA; Akimova LN
    Biokhimiia; 1966; 31(5):983-7. PubMed ID: 4878119
    [No Abstract]   [Full Text] [Related]  

  • 12. Vibrational analysis of amino acids and short peptides in hydrated media. VIII. Amino acids with aromatic side chains: L-phenylalanine, L-tyrosine, and L-tryptophan.
    Hernández B; Pflüger F; Adenier A; Kruglik SG; Ghomi M
    J Phys Chem B; 2010 Nov; 114(46):15319-30. PubMed ID: 21043521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Degradation of nitrogen mustard N-oxide in aqueous solutions].
    ARNOLD H; BROCK N; HOHORST HJ
    Arzneimittelforschung; 1957 Dec; 7(12):735-9. PubMed ID: 13499148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumour chemotherapy. XXXIX Synthesis of 2-methyl-5-bis (beta-chloroethyl) aminophenylalanine and 2-bis (beta-chloroethyl)-aminomethyl-5-nitrophenylalanine (author's transl)].
    Zheng YY; Ren YF
    Yao Xue Xue Bao; 1979 Nov; 14(11):676-81. PubMed ID: 552207
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
    Jugstand W; Gutsche W; Wiangke H
    Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
    [No Abstract]   [Full Text] [Related]  

  • 17. Bivalent bendamustine and melphalan derivatives as anticancer agents.
    Scutaru AM; Wenzel M; Gust R
    Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of neoplasms with a phenylalanine derivative of nitrogen mustard].
    ESTEVEZ RA; TRIMBOLI DE ESTEVEZ O
    Sem Med; 1958 Jan; 112(4):119-29. PubMed ID: 13556029
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy.
    Benckhuysen C; Ter Hart HG; Van Dijk PJ
    Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.